Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetracycline

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 3, 2007, Pages 432-437

  Borovskaya, A D ^a   Malakhova, M V ^a   Vereshchagin, V A ^a   Il'ina, E N ^a   Govorun, V M ^a   Priputnevich, T V ^a   Al Hafagi, N ^a   Kubanova, A A ^a  

^a Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology   (Russian Federation)

Author keywords

Mass spectrometry; Minisequencing; N.gonorrhoeae; Resistance; Tetracycline

Indexed keywords

BACTERIAL PROTEIN; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2; PORIN; PROTEIN MTRR; PROTEIN RPSJ; PROTEIN TET(M); TETRACYCLINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; RUSSIAN FEDERATION; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; GENETIC MARKERS; GENOTYPE; GONORRHEA; HUMANS; MUTATION; NEISSERIA GONORRHOEAE; RUSSIA; TETRACYCLINE; TETRACYCLINE RESISTANCE;

NEISSERIA GONORRHOEAE;

EID: 37749011411     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0347-9     Document Type: Article

References (14)

1. V. A. Vereshchagin, E. N. Il'ina, M. M. Zubkov, et al., Mol. Biol., 39, No. 6, 923-932 (2005).
2. A. A. Kubanova, M. M. Vasil'ev, T. V. Priputnevich, et al., Vestn. Dermatol. Venerol., No. 2, 40-44 (2005).
3. M. V. Malakhova, V. A. Vereshchagin, E. N. Il'ina, et al., Byull. Eksp. Biol. Med., 141, No. 5, 549-554 (2006).
4. Centralized information system for infectious diseases (CISID)/WHO. http://data.euro.who.int/cisid/.
5. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 15 Informational Suppl. Wayne, 2002. CLSI document No. M100-S15.
6. S. L. Cousin Jr., W. L. Whittington, and M. C. Roberts, J. Antimicrob. Chemother., 51, No. 1, 131-133 (2003).
7. European health for all database (HFA-DB): Databases of National Health Statistics and Other Data on the Health Situation in European Countries/ WHO. http://www.euro.who.int/hfadb.
8. M. J. Gill, S. Simjee, K. Al-Hattawi, et al., Antimicrob. Agents Chemother., 42, No. 11, 2799-2803 (1998).
9. K. E. Hagman, W. Pan, B. G. Spratt, et al., Microbiology, 141, Pt. 3, 611-622 (1995).
10. M. Hu, S. Nandi, C. Davies, and R. A. Nicholas, Antimicrob. Agents Chemother., 49, No. 10, 4327-4334 (2005).
11. S. A. Morse, S. R. Johnson, J. W. Biddle, and M. C. Roberts, Ibid., 30, No. 5, 664-670 (1986).
12. H. Nikaido, Curr. Opin. Microbiol., 1, No. 5, 516-523 (1998).
13. M. Olesky, M. Hobbs, and R. A. Nicholas, Antimicrob. Agents Chemother., 46, No. 9, 2811-2820 (2002).
14. W. L. Veal, R. A. Nicholas, and W. M. Shafer, J. Bacteriol., 184, No. 20, 5619-5624 (2002).